Glutamate carboxypeptidase II inhibitor

Glutamate carboxypeptidase II inhibitor has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Nov 2, 2026: “Brain enzyme contributes to memory problems after surgery in mice”.

Intervention

1 paper studies it1 findingUpdated Jul 1, 2026

See all 1 papers on glutamate carboxypeptidase II inhibitor

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

1 lab in 1 country

Funders: Cell Science Research Foundation and others

Animals1

What did studies of glutamate carboxypeptidase II inhibitor find?

Studies of glutamate carboxypeptidase II inhibitor measured 1 outcome; the most studied are cognitive function (1 study).

Cognitive function

upin mice1

1 study

Glutamate carboxypeptidase II inhibitor improves cognitive function in mice (pharmacological GCPII inhibition).
“consistent with pharmacological GCPII inhibition ameliorating glutamate levels, AQP4 polarization, and cognitive performance”
Animalspharmacological GCPII inhibition
Brain enzyme contributes to memory problems after surgery in mice
Alzheimer's & dementia : the journal of the Alzheimer's AssociationJul 1, 2026

Latest

1 paper in 12 months

Alzheimer's & DementiaJul 10

Brain enzyme contributes to memory problems after surgery in mice

Experiments in mice aged 18–20 months implicated an enzyme in brain support cells in male-specific memory problems during the week after surgery.Experiments in mice aged 18–20 months implicated an enzyme in brain support cells in male-specific memory problems during the week after surgery.

Mouse studyMechanisms

Paper